Published in Curr Med Res Opin on November 04, 2010
Sublingual immunotherapy: World Allergy Organization position paper 2013 update. World Allergy Organ J (2014) 1.74
Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial. Respir Res (2016) 0.84
Allergen-specific immunotherapy in pediatric allergic asthma. Asia Pac Allergy (2016) 0.75
Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial. Int J Dermatol (2003) 0.98
C-reactive protein in hypertensive disorders in pregnancy. Clin Appl Thromb Hemost (2006) 0.95
Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study. Curr Med Res Opin (2007) 0.94
D-dimer before chemotherapy might predict venous thromboembolism. Blood Coagul Fibrinolysis (2009) 0.92
Efficacy and tolerability of a new chlorhexidine-based vaginal gel in vaginal infections. Curr Med Res Opin (2004) 0.85
Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial. J Eur Acad Dermatol Venereol (2006) 0.85
Efficacy of a new aluminium salt thermophobic foam in the treatment of axillary and palmar primary hyperhidrosis: a pilot exploratory trial. Curr Med Res Opin (2005) 0.83
The VISYT trial: Venom Immunotherapy Safety and Tolerability with purified vs nonpurified extracts. Ann Allergy Asthma Immunol (2009) 0.83
Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case-control study on 171 patients. The EFESO-children multicenter trial. Pediatr Allergy Immunol (2009) 0.80
A multicenter, randomized, parallel-group trial assessing compliance, tolerability, safety, and efficacy to treatment with grass allergy tablets in 261 patients with grass pollen rhinoconjunctivitis. J Allergy (Cairo) (2011) 0.78
Sensitivity and specificity of different skin prick tests with latex extracts in pediatric patients with suspected natural rubber latex allergy--a cohort study. Pediatr Allergy Immunol (2008) 0.77
Efficacy of AT in pre-eclampsia: a case-control prospective trial. Thromb Haemost (2004) 0.77
Successful treatment of bacterial vaginosis with a policarbophil-carbopol acidic vaginal gel: results from a randomised double-blind, placebo-controlled trial. Eur J Obstet Gynecol Reprod Biol (2005) 0.77
Efficacy and tolerability of natural synergised pyrethrins in a new thermo labile foam formulation in topical treatment of scabies: a prospective, randomised, investigator-blinded, comparative trial vs. permethrin cream. Eur J Dermatol (2003) 0.76
Allergy immunotherapy tablet: Grazax® for the treatment of grass pollen allergy. Expert Rev Clin Immunol (2011) 0.76
Local rhamnosoft, ceramides and L-isoleucine in atopic eczema: a randomized, placebo controlled trial. Pediatr Allergy Immunol (2014) 0.75
Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy. J Allergy Clin Immunol (2009) 0.75
Recent progress in the therapeutic management of pre-eclampsia. Expert Opin Pharmacother (2004) 0.75
Efficacy of topical 10% urea-based lotion in patients with ichthyosis vulgaris: a two-center, randomized, controlled, single-blind, right-vs.-left study in comparison with standard glycerol-based emollient cream. Curr Med Res Opin (2011) 0.75
Approaching atopic dermatitis treatment differently: from skin barrier preservation to allergen-specific immunotherapy. Immunotherapy (2012) 0.75
Use of a urea, arginine and carnosine cream versus a standard emollient glycerol cream for treatment of severe xerosis of the feet in patients with type 2 diabetes: a randomized, 8 month, assessor-blinded, controlled trial. Curr Med Res Opin (2015) 0.75
The safety of a novel sublingual rush induction phase for latex desensitization. Curr Med Res Opin (2010) 0.75
The impact of antithrombotic prophylaxis on infectious complications in cancer patients with central venous catheters: an observational study. Blood Coagul Fibrinolysis (2009) 0.75